Preservative-free treatment in glaucoma: who, when, and why?

被引:35
|
作者
Stalmans, Ingeborg [1 ]
Megevand, Gordana Sunaric [2 ]
Cordeiro, M. Francesca [3 ]
Hommer, Anton [4 ]
Rossetti, Luca [5 ]
Goni, Francisco [6 ]
Heijl, Anders [7 ]
Bron, Alain [8 ]
机构
[1] Katholieke Univ Leuven Hosp, Dept Ophthalmol, B-3000 Louvain, Belgium
[2] Rothschild Mem, Geneva, Switzerland
[3] Western Eye Hosp, London, England
[4] Hera Hosp, Vienna, Austria
[5] Univ Milan, San Paolo Hosp, Eye Clin, Milan, Italy
[6] SIOVO, Barcelona, Spain
[7] Lund Univ, Dept Ophthalmol, Skane Univ Hosp, Malmo, Sweden
[8] Univ Hosp, Dept Ophthalmol, Dijon, France
关键词
Glaucoma; Intraocular pressure-lowering agents; Ocular surface; Preservative; OCULAR SURFACE DISEASE; TOPICAL ANTIGLAUCOMA MEDICATION; QUALITY-OF-LIFE; BENZALKONIUM CHLORIDE; DRY EYE; BETA-BLOCKER; TEAR FILM; CORNEAL; DRUGS; PREVALENCE;
D O I
10.5301/ejo.5000270
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To review and summarize the available literature on the effect of preservatives on the eye, to provide practical guidance for the clinical assessment of the ocular surface in glaucoma patients, and to define patient populations that might benefit from preservative-free topical intraocular pressure (IOP)-lowering agents. Methods: This manuscript is based on a combination of a literature review on preservatives and the eye and expert opinion from glaucoma specialists with an interest in ocular surface disease. Results: There is an increasingly recognized association between eyedrop preservatives and ocular surface disease. Preservative-free therapy is now available for a wide range of active compounds, although there are still some misconceptions regarding their appropriate use. For patients treated topically for glaucoma or ocular hypertension, a rough estimate could be that 20% may need treatment with topical IOP-reducing agents that are free from preservatives. Conclusions: This review provides an up-to-date account of the literature regarding preservatives and the eye, as well as suggestions and recommendations on to when to use preservative-free antiglaucoma treatment.
引用
收藏
页码:518 / 525
页数:8
相关论文
共 50 条
  • [21] Preserved Versus Preservative-Free Latanoprost for the Treatment of Glaucoma and Ocular Hypertension: A Post Hoc Pooled Analysis
    Harasymowycz, Paul
    Hutnik, Cindy
    Rouland, Jean-Francois
    Negrete, Francisco J. Munoz
    Economou, Mario A.
    Denis, Philippe
    Baudouin, Christophe
    ADVANCES IN THERAPY, 2021, 38 (06) : 3019 - 3031
  • [22] Tear cytokine profile of glaucoma patients treated with preservative-free or preserved latanoprost
    Martinez-de-la-Casa, Jose M.
    Perez-Bartolome, Francisco
    Urcelay, Elena
    Santiago, Jose L.
    Moreno-Montanes, Javier
    Arriola-Villalobos, Pedro
    Benitez-del-Castillo, Jose M.
    Garcia-Feijoo, Julian
    OCULAR SURFACE, 2017, 15 (04): : 723 - 729
  • [23] Preservative-free influenza vaccine
    Banzhoff, A
    Schwenke, C
    Febbraro, S
    IMMUNOLOGY LETTERS, 2000, 71 (02) : 91 - 96
  • [24] Switching from a preserved to a preservative-free prostaglandin preparation in topical glaucoma medication
    Uusitalo, Hannu
    Chen, Enping
    Pfeiffer, Norbert
    Brignole-Baudouin, Francoise
    Kaarniranta, Kai
    Leino, Markku
    Puska, Paivi
    Palmgren, Elina
    Hamacher, Thomas
    Hofmann, Guenter
    Petzold, Gernot
    Richter, Ulrich
    Riedel, Tobias
    Winter, Martin
    Ropo, Auli
    ACTA OPHTHALMOLOGICA, 2010, 88 (03) : 329 - 336
  • [25] Impact of supply problems of preservative-free glaucoma medications on patients and hospital staff
    Shah, Shima
    Theodossiades, Julia
    Chapman, Kristin
    Murdoch, Ian
    OPHTHALMIC AND PHYSIOLOGICAL OPTICS, 2015, 35 (02) : 236 - 241
  • [26] New Preservative-Free Formulation for the Enhanced Ocular Bioavailability of Prostaglandin Analogues in Glaucoma
    Alviset, Gabriel
    Corvis, Yohann
    Hammad, Karim
    Lemut, Josiane
    Maury, Marc
    Mignet, Nathalie
    Boudy, Vincent
    PHARMACEUTICS, 2022, 14 (02)
  • [27] Efficacy and patient tolerability of preservative-free latanoprost compared with preservative prostaglandin analogs in patients with ocular hypertension or glaucoma
    El Ameen, A.
    Vandermeer, G.
    Pisella, P. J.
    ACTA OPHTHALMOLOGICA, 2016, 94
  • [28] Randomized Clinical Trial Of The Efficacy And Safety Of Preservative-free Tafluprost And Preservative-free Timolol In Patients With Open-angle Glaucoma (OAG) Or Ocular Hypertension (OHT) In India
    Chabi, Almira
    Lupinacci, Robert
    Baranak, Christine
    Herring, W. Joseph
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [29] Intravitreal preservative-free triamcinolone acetonide for the treatment of macular oedema
    S J Bakri
    A Shah
    N S Falk
    P M Beer
    Eye, 2005, 19 : 686 - 688
  • [30] Intravitreal preservative-free triamcinolone acetonide for the treatment of macular oedema
    Bakri, SJ
    Shah, A
    Falk, NS
    Beer, PM
    EYE, 2005, 19 (06) : 686 - 688